Market Value1,394,707,000
Total Holdings54
File Date2020-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
DTIL / Precision BioSciences, Inc.
AKRO / Akero Therapeutics, Inc.
ACRS / Aclaris Therapeutics, Inc.
FTSV / Forty Seven, Inc.
COLL / Collegium Pharmaceutical, Inc.
KRTX / Karuna Therapeutics, Inc.
US62857M1053 / MyoKardia, Inc.
SELB / Selecta Biosciences Inc
PASG / Passage Bio, Inc.
IGMS / IGM Biosciences, Inc.
KDMN / Kadmon Holdings Inc
CALT / Calliditas Therapeutics AB (publ) - Depositary Receipt (Common Stock)
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
KDNY / Chinook Therapeutics Inc
KNSA / Kiniksa Pharmaceuticals, Ltd.
ARWR / Arrowhead Pharmaceuticals, Inc.
ATRC / AtriCure, Inc.
RCKT / Rocket Pharmaceuticals, Inc.
ZGNX / Zogenix Inc
SAGE / Sage Therapeutics, Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
SRRA / Sierra Oncology Inc
ZYME / Zymeworks Inc.
EIGR / Eiger BioPharmaceuticals, Inc.
KALA / KALA BIO, Inc.
CBAY / CymaBay Therapeutics, Inc.
RVMD / Revolution Medicines, Inc.
GLMD / Galmed Pharmaceuticals Ltd.
ARQT / Arcutis Biotherapeutics, Inc.
NFH / New Frontier Health Corporation - Class A
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
MTNB / Matinas BioPharma Holdings, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
MEIP / MEI Pharma, Inc.
US2103731061 / Constellation Pharmaceuticals Inc
TCDA / Tricida Inc
AMRS / Amyris Inc
VSTM / Verastem, Inc.
AVRO / AVROBIO, Inc.
CLDX / Celldex Therapeutics, Inc.
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
ISEE / IVERIC bio Inc
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
SVA / Sinovac Biotech, Ltd.
VYNE / VYNE Therapeutics Inc.
LRMR / Larimar Therapeutics, Inc.
KURA / Kura Oncology, Inc.
BDTX / Black Diamond Therapeutics, Inc.
CDXS / Codexis, Inc.
AVDL / Avadel Pharmaceuticals plc
ZLAB / Zai Lab Limited - Depositary Receipt (Common Stock)
GTH / Genetron Holdings Limited - Depositary Receipt (Common Stock)
AUPH / Aurinia Pharmaceuticals Inc.
FIXX / Homology Medicines, Inc.
INSM / Insmed Incorporated
KALV / KalVista Pharmaceuticals, Inc.
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)